e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Idiopathic pulmonary fibrosis: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
L. Richeldi (Southampton, United Kingdom)
Source:
International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Session:
Idiopathic pulmonary fibrosis: from the bench to the bedside
Session type:
Poster Discussion
Number:
4892
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Richeldi (Southampton, United Kingdom). FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF. 4892
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
1 year RV/TLC change as a predictor of long term decline of FEV1
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010
Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Re-assessing the importance of FEV
1
decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015
LVRS does not accelerate rate of decline in FEV
1
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003
Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up
Source: Eur Respir J 2016; 47: 742-750
Year: 2016
The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Individual decline of FEV1 show diversity in COPD
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Monocyte count and decline in forced vital capacity (FVC) in patients with IPF
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
The correlation of annual rate of FEV
1
decline with the temperature of expired air in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
Within session variability of FEV1 and FVC pre- and post-bronchodilation
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019
Distinguishing hyperinflation from combined restriction in patients with reduced FEV
1
/FVC and FVC on spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 202s
Year: 2006
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Biomarkers to predict FEV1 decline in smokers and early-onset COPD.
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020
Frequent exacerbations in COPD are associated with accelerated rate of FEV
1
decline
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept